In The News
High Court asked to decide when a judge’s copying and pasting crosses a line
Judge facing recusal bid clarifies relationship with litigation funder
Google’s ad tech dominance probed by second class action firm
AMP class action ‘in search of a case’ after four years, court told
NSW Police can’t appeal ruling on group members’ names in strip search class action
Judge OKs cutting edge argument in $900M class action against CBA
Real estate listings giant REA accuses rival Domain of scraping its data
Allergan hit with class action over breast implants linked to cancer
Bayer launches High Court appeal to revive Xarelto patents
‘Replete with error’: Firm fights $5.4M security order in Macquarie class action
Please login to bookmarkClose

Reckitt Benckiser has been ordered to pay all of GlaxoSmithKline’s legal bill after a judge found the drug giant misled consumers with claims that Nurofen was a more effective pain killer than its rival’s Panadol.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au